Literature DB >> 24888868

In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.

Chun-Hsing Liao1, Yu-Tsung Huang1, Hsih-Yen Tsai1, Po-Ren Hsueh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24888868     DOI: 10.1016/j.ijantimicag.2014.03.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

2.  β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Mostafa Aboutaleb; George Sakoulas; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2015-02-01       Impact factor: 5.790

3.  Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?

Authors:  Laura Herrera-Hidalgo; Arístides de Alarcón; Luis Eduardo López-Cortes; Rafael Luque-Márquez; Luis Fernando López-Cortes; Alicia Gutiérrez-Valencia; María Victoria Gil-Navarro
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 4.  Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives.

Authors:  Laura Herrera-Hidalgo; Arístides de Alarcón; Luis E López-Cortes; Rafael Luque-Márquez; Luis F López-Cortes; Alicia Gutiérrez-Valencia; María V Gil-Navarro
Journal:  Antibiotics (Basel)       Date:  2020-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.